Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC 4.0mAbs

Clonal tree frequency analysis reveals affinity determinants and enables antibody lead optimization

  1. 1Biologics Engineering, Oncology, AstraZeneca R&D, Cambridge, UK
  2. 2Department of Microbes, Infection and Microbiomes, Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK
  3. 3Respiratory & Immunology, Biopharmaceuticals, AstraZeneca R&D, Cambridge, UK

Abstract

Understanding the sequence determinants of antibody affinity within a clonal family is a central challenge in therapeutic antibody discovery. Here, we applied amino acid frequency analysis to a large phylogenetic clonal tree of anti-ST2 monoclonal antibodies, where V(D)J recombination is constant and only somatic hypermutations vary. We identified M33I and L100I in the heavy chain as key affinity-governing mutations, corroborated by AlphaFold2 structural modeling and molecular dynamics free‑energy decomposition. The I33/I100 genotype predicted significantly improved functional neutralization of IL-33-induced IL-6 release and was associated with a higher transcriptomic affinity score (Hiscore). Prospective mutagenesis of three low-affinity parent antibodies achieved up to 10-fold affinity improvement, establishing a workflow integrating sequence statistics, structural modeling, transcriptomics and MD simulation for rational lead optimization.

Related

  1. Optimal Maturation Protocols for High-Affinity Antibody Targets: A Path-Integral Approach
    Marian Huot, Marco Molari, Rémi Monasson +1
    PRX LifePeer-reviewedCC BY 4.0Full textGenetics & genomicsHAL
  2. CIR-DDG: backbone-agnostic residual correction of antibody-antigen affinity changes with explicit cross-chain geometry
    Weilun Yu, Zhiheng Zou, Yonggui Huang +6
    arXivPreprintarXiv licenceFull textBioinformatics & computational biologyarXiv
  3. Antibody-Antigen Affinity Prediction with Chain-Aware Protein Language Modeling
    H. Singh, A. Malhotra, S. P. Srivastava +2
    bioRxivPreprintCC BYFull textBioinformatics & computational biologybioRxiv
  4. Model‐Informed First‐In‐Human Dose Selection for AZD2796, a High‐Affinity Anti‐LILRB2 Antibody
    Mark Penney, Sofia Ferreira, Karla Maloveste +8
    CPT: Pharmacometrics & Systems PharmacologyPeer-reviewedCC BY-NC 4.0Full textImmunologyPMC
  5. A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability
    M. Frank Erasmus, Daniel Bedinger, Elizabeth Hopkins +97
    Nature BiotechnologyPeer-reviewedCC BYFull text6 citedImmunologyOpenAlex
BibTeX
@article{waterhouse2026clonal,
  title = {{Clonal tree frequency analysis reveals affinity determinants and enables antibody lead optimization}},
  author = {Mark Waterhouse and Shuang Gu and Maria Tsoumpeli and Ben Dugan and Karanjot Sandhu and Chiara Ciminieri and Zenon Zenonos and Suzanne Cohen and Darren J. Schofield and Xavier Romero-Ros and Michele Chirichella},
  journal = {mAbs},
  year = {2026},
  month = nov,
  doi = {10.1080/19420862.2026.2755659},
  url = {https://doi.org/10.1080/19420862.2026.2755659},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Clonal tree frequency analysis reveals affinity determinants and enables antibody lead optimization
AU  - Mark Waterhouse
AU  - Shuang Gu
AU  - Maria Tsoumpeli
AU  - Ben Dugan
AU  - Karanjot Sandhu
AU  - Chiara Ciminieri
AU  - Zenon Zenonos
AU  - Suzanne Cohen
AU  - Darren J. Schofield
AU  - Xavier Romero-Ros
AU  - Michele Chirichella
PY  - 2026
DA  - 2026/11/04
JO  - mAbs
DO  - 10.1080/19420862.2026.2755659
UR  - https://doi.org/10.1080/19420862.2026.2755659
AB  - Understanding the sequence determinants of antibody affinity within a clonal family is a central challenge in therapeutic antibody discovery. Here, we applied amino acid frequency analysis to a large phylogenetic clonal tree of anti-ST2 monoclonal antibodies, where V(D)J recombination is constant and only somatic hypermutations vary. We identified M33I and L100I in the heavy chain as key affinity-governing mutations, corroborated by AlphaFold2 structural modeling and molecular dynamics free‑energy decomposition. The I33/I100 genotype predicted significantly improved functional neutralization of IL-33-induced IL-6 release and was associated with a higher transcriptomic affinity score (Hiscore). Prospective mutagenesis of three low-affinity parent antibodies achieved up to 10-fold affinity improvement, establishing a workflow integrating sequence statistics, structural modeling, transcriptomics and MD simulation for rational lead optimization.
SN  - 1942-0862
SN  - 1942-0870
ER  -